维普中文期刊产品整合服务
18篇 您的检索式:作者名="Marcin E"
    题名 作者 年代 出处 被引量
1每日1次利拉鲁肽与每日2次艾塞那肽治疗2型糖尿病比较:一项为期26周的随机、平行组、多国开放标记试验(LEAD-6)显示文摘背景与大多数抗高血糖药物不同,胰高血糖素样肽-1(GLP-1)受体激动剂的药理作用依赖于葡萄糖水平,并且有助于减轻患者体重。本研究比较了利拉鲁肽(一种人GLP-1类似物)与艾塞那肽(一种基于醋酸艾塞那肽的GLP-1受体激动剂)治疗2型糖尿病的疗效和安全性。方法对于用最大耐受剂量二甲双胍或(和)磺脲仍控制不良的2型糖尿病成年患者,根据之前服用的抗糖尿病药物进行分层,并随机分配这些患者额外接受利拉鲁肽1.8mg每El1次(n=233)或艾塞那肽10μg每日2次(n=231),进行为期26周的开放标记、平行组、多国(15个国家)研究。主要终点是糖化血红蛋白(HbA1c)水平的变化,疗效分析采用意向性治疗分析。本试验在Clinical Trial.gov注册,注册号为NCT00518882。结果受试者的HbA1c平均基线水平为8.2%。与艾塞那肽相比,利拉鲁肽能显著降低HbA1c平均水平[-1.12%(s=0.08%)vs-0.79%(s=0.08%);疗效差异估计值为-0.33%,95%CI-0.47%~-0.18%;P〈0.0001],并且利拉鲁肽组有更多患者HbA1c水平低于7%(54%vs543%;OR 2.02,95%CI 1.31~3.11;P=0.0015)。利拉鲁肽降低平均空腹血糖的能力也显著优于艾塞那肽[-1.61mmol/Lb=0.20)vs-0.60mmol/L(s=0.20);疗效差异估计值为-1.01mmol/L,95%CI-1.37—-0.65;P〈0.0001],但是其降低早餐和晚餐后血糖的能力较艾塞那肽差。两种药物促进患者体重减轻的作用相似(利拉鲁肽组~3.24kg vs艾塞那肽组-2.87地)。耐受性均较好,但与艾塞那肽组相比,利拉鲁肽组患者恶心的持续时间较短(估计的治疗相关事件率比值为0.448,P〈0.0001),轻度低血糖的发生率也较低(每患者每年的事件发生数为1.93vs2.60;发生率比值为0.55,95%C10.34~0.88:P=0.0131;轻度低血糖的发生率为25.5%掷33.6%)。2例同时注射艾塞那肽和一种磺脲类药物的患者发生了严重的低血糖。结论相对于艾塞那肽每日2次,利拉鲁肽每日1次能显著改善血糖控制水平,且患者的耐受性更好。研究结果提示利拉鲁肽或许是2型糖尿病的一种治疗选择,特别是在减轻体重和低血糖风险作为主要考虑因素的情况下。John B Buse Julia Rosenstock Giorgio Sesti Wolfgang E Schmidt Eduard Montanya Jason H Brett Marcin Zychma Lawrence Blonde 赵乐(译) 2009世界临床医学2009,,11:3
2Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)显示文摘John B Buse Julio Rosenstock Giorgio Sesti Wolfgang E Schmidt Eduard Montanya Jason H Brett Marcin Zychma Lawrence Blonde 2009The Lancet2009,,9683:2
3Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)显示文摘John B Buse Julio Rosenstock Giorgio Sesti Wolfgang E Schmidt Eduard Montanya Jason H Brett Marcin Zychma Lawrence Blonde 2009The Lancet . 2009 (9683)2009,,9683:1
4Nurse staffing and unplanned extubation in the pediatric intensive care unit显示文摘Marcin JP Rutan E Brown JP 0,,03:1
5A General Method for the Preparation of 2,2-Disubstituted 1-Nitroalkenes 显示文摘Denmark S E Marcin L R 1993J Org Chem1993,58,15:1
6Clinical application of 3D prebent titanium implants for orbital floor fractures 显示文摘Marcin K Marcin E Piotr L 2009Journal of Cranio-Maxillofacial Surgery2009,37,4:1
7Decreased plasma adiponectin concentration in patients with essential hypertension显示文摘Marcin Adamczak Andrzej Wi e ? cek Tohru Funahashi Jerzy Chudek Franciszek Kokot Yuji Matsuzawa 2003American Journal of Hypertension2003,,1:1
8Prevalence of au- tism spectrum disorders in guanajuato, Mexico: the leon survey显示文摘FOMBONNE E MARCIN C MANERO A C 2016J Autism Dev Disord2016,46,5:1
9Decreased plasma adiponectin concentration in patients with essential hypertension显示文摘Marcin Adamczak Andrzej Wi e ? cek Tohru Funahashi Jerzy Chudek Franciszek Kokot Yuji Matsuzawa 2003American Journal of Hypertension2003,,1:1
10Joint effect of phosphorus limitation and temperature on alkaline phosphatase activity and somatic growth in Daphnia magna显示文摘Marcin W W Marcia K James J E 2011Oecologia2011,,165:1
11Nurse staffing and un- planned extubation in the pediatric intensive care unit显示文摘Marcin JP Rutan E Rapetti PM 2005Pediatr Crit Care Med2005,6,3:1
12Clinical application of 3D prebent titanium implants for orbital fractures 显示文摘Marcin K Martin E Piotr L 2009J Craniomaxillofac Surg2009,37,4:1
13Nurse staffing and unplanned extubation in the pediatric intensive care unit显示文摘Marcin JP Rutan E Rapetti PM 2005Pediatr Crit Care Med2005,6,3:1
14Nurse staffing and unplanned ex- tubation in the pediatric intensive care unit显示文摘Marcin JP Rutan E Rapetti PM Pediatr Crit Care Med0,6,3:1
15Nurse staffing and unplanned extubation in the pediatric intensive care unit 显示文摘Marcin JP Rutan E Rapetti PM 2005Pediatr Crit Care Med2005,6,3:1
16Nurse staffing and unplanned extubation in the pediatric intensive care unit显示文摘Marcin JP Rutan E Rapetti PM 2005Pediatr Crit Care Med2005,6,3:1
17Joint effect of phosphorus limitation and temperature on alkaline phosphatase activity and somatic growth in Daphnia magna显示文摘Marcin W W Marcia K James J E 2011Oecologia2011,165,:1
18饲料中添加鼠尾草提取物对鸡的生化指标、内脏器官重量和沙门氏菌数的影响显示文摘研究在饲料中添加鼠尾草提取物对受肠炎沙门氏菌PT4型(SE)感染鸡的生化指标及身体器官的重量变化的影响。试验分为5个处理,分别为基础日粮,基础日粮中添加鼠尾草提取物(S),基础日粮+SE(SE),基础日粮+S+SE(SSE)的提取物。在接种(p.i.)后的第4天,与SE组相比,SSE组可显著降低碱性磷酸酶(ALP)和谷丙转氨酶(ALT)活性和葡萄糖及胆红素的浓度。然而,在接种后的第18天,添加鼠尾草提取物组的胆红素水平和ALT活性较低。在两次采样中,饲料添加鼠尾草提取物都使鸡的肝脏、脾脏、盲肠及在鸡的肠道黏液中沙门氏菌数显著下降(P<0.05)。研究结果表明,加入鼠尾草提取物的饲粮可以有效地保护受SE感染的鸡。Piesova E Makova Z Levkut M Faixova Z Pistl J Marcin A 2013饲料博览2013,,1:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费